HeartBeam Inc.

NASDAQ: BEAT · Real-Time Price · USD
1.82
0.12 (7.06%)
At close: Jun 02, 2025, 3:59 PM
1.81
-0.55%
After-hours: Jun 02, 2025, 04:04 PM EDT

Company Description

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting.

The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease.

Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring.

The company was incorporated in 2015 and is headquartered in Santa Clara, California.

HeartBeam Inc.
HeartBeam Inc. logo
Country United States
IPO Date Nov 11, 2021
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 21
CEO Robert P. Eno

Contact Details

Address:
2118 Walsh Avenue
Santa Clara, California
United States
Website https://www.heartbeam.com

Stock Details

Ticker Symbol BEAT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001779372
CUSIP Number 42238H108
ISIN Number US42238H1086
Employer ID 47-4881450
SIC Code 3841

Key Executives

Name Position
Robert P. Eno Chief Executive Officer, Chief Business Officer & Director
Kenneth Persen Chief Technology Officer
Timothy Cruickshank Chief Financial Officer
Dr. Branislav Vajdic Ph.D. Founder, President & Director
Dr. Lance Myers Ph.D. Chief Artificial Intelligence Scientist
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. Member of Scientific Advisory Board & Chief Medical Officer
Richa Gujarati Senior Vice President of Product
Richard M. Ferrari Executive Chairman

Latest SEC Filings

Date Type Title
May 29, 2025 DEF 14A Filing
May 19, 2025 PRE 14A Filing
May 13, 2025 10-Q Quarterly Report
May 05, 2025 8-K Current Report
May 01, 2025 4 Filing
May 01, 2025 4 Filing
May 01, 2025 4 Filing
May 01, 2025 4 Filing
Apr 25, 2025 8-K Current Report
Mar 13, 2025 10-K Annual Report